No black box warning on record for Neurozyl
As of the latest FDA labeling reviewed, Neurozyl (LIDOCAINE HCL 4.12 %) does not carry a black box warning. Standard warnings and precautions still apply — see the full Neurozyl medicine page for the complete safety profile.